Xoma reported $6.51M in Current Liabilities for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Agios Pharmaceuticals AGIO:US $ 57.9M 2.75M
Ardelyx ARDX:US $ 68.77M 10.98M
Biomarin Pharmaceutical BMRN:US $ 514.9M 71.55M
Bluebird Bio BLUE:US $ 266.56M 18.79M
Celldex Therapeutics CLDX:US $ 14.18M 0.31M
Chimerix CMRX:US $ 26.29M 1.37M
Curis CRIS:US $ 9.47M 1.61M
Eli Lilly And LLY:US $ 13682M 1411.2M
Emergent Biosolutions EBS:US $ 365.4M 12.4M
Epizyme EPZM:US $ 44.74M 3.84M
Life Technologies LIFE:US $ 5.82M 1.46M
Macrogenics MGNX:US $ 68.86M 1.06M
Novartis NVS:US $ 29880M 247M
Novartis NOVN:VX SF 29880M 247M
Prothena PRTA:US 29.2M 23.7M
Regeneron Pharmaceuticals REGN:US $ 3714.8M 17.6M
Teva Pharmaceutical Industries TEVA:US $ 11825M 866M
Xoma XOMA:US $ 6.51M 221K
YTE INCY:US $ 742.71M 82.39M